What is the significance of a boot‑shaped cardiac silhouette on chest imaging and what are the recommended next diagnostic and management steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Boot-Shaped Heart: Tetralogy of Fallot Until Proven Otherwise

A boot-shaped cardiac silhouette on chest imaging is pathognomonic for Tetralogy of Fallot (TOF) and mandates immediate echocardiography to confirm the diagnosis and define the anatomy 1.

What Creates the Boot Shape

The characteristic boot-shaped (or "coeur en sabot") appearance results from:

  • Upturned cardiac apex due to right ventricular hypertrophy
  • Concave main pulmonary artery segment from pulmonary stenosis and hypoplastic pulmonary arteries
  • Right aortic arch (present in 25% of cases)

This radiographic finding is highly specific for TOF, the most common cyanotic congenital heart defect occurring in 3-5 per 10,000 live births 2.

Immediate Diagnostic Steps

First-Line Imaging

Transthoracic echocardiography is the primary diagnostic modality to confirm TOF and define:

  • The four cardinal features: ventricular septal defect (VSD), right ventricular outflow tract (RVOT) obstruction, overriding aorta, and right ventricular hypertrophy
  • Pulmonary valve and branch pulmonary artery anatomy
  • Coronary artery anomalies (critical for surgical planning)
  • Associated defects (atrial septal defect, right aortic arch, additional VSDs)

Advanced Imaging Indications

Cardiac MRI (CMR) is reasonable prior to definitive surgery when echocardiography cannot adequately visualize 3:

  • Aortic arch anomalies
  • Discontinuous branch pulmonary arteries
  • Aorto-pulmonary collaterals
  • Complex TOF anatomy or situs anomalies

Cardiac CT may be considered if airway anatomy or coronary relationships within stents need delineation 3.

Management Algorithm

Neonates and Infants (<6 months)

Symptomatic patients (hypercyanotic spells, ductal-dependent pulmonary circulation) weighing <4 kg:

  • Modified Blalock-Taussig shunt (BTS) as palliation
  • Complete repair at 6-12 months 4

Asymptomatic patients weighing <4 kg with threatened pulmonary artery isolation:

  • BTS followed by repair at 6-12 months 4

All other patients: Complete repair after 6 months of age 4

Surgical Approach

The 2023 AATS expert consensus emphasizes 2:

  • Smallest possible ventriculotomy (both transatrial and transventricular approaches are effective)
  • Pulmonary valve preservation when possible; reconstruction if unsalvageable
  • Confirmation of adequate RVOT obstruction relief at operation conclusion
  • Further intervention if significant fixed anatomical obstruction identified

Long-Term Surveillance

Post-Repair Monitoring

CMR is indicated for baseline and serial evaluation 3:

  • Every 2-3 years if not dilated and ≥10 years of age
  • Yearly if dilated and approaching pulmonary valve replacement (PVR) thresholds

Critical parameters to quantify 3:

  • Biventricular volumes, ejection fraction, cardiac index
  • Pulmonary regurgitation (PR), tricuspid regurgitation (TR), aortic regurgitation (AR)
  • Branch pulmonary artery flows
  • RVOT and aortic root anatomy
  • Discrete myocardial scarring

Pulmonary Valve Replacement Considerations

Annual CMR is useful when surgery is being considered for 3:

  • RV indexed end-diastolic volumes 140-180 cc/m² (threshold debated)
  • Large RVOT aneurysms or obstruction
  • Sustained tachyarrhythmias related to RV volume overload
  • Left-to-right shunt with Qp/Qs >1.5
  • Severe AR or dilation

Critical Pitfalls to Avoid

  1. Do not delay echocardiography - The boot-shaped heart is not a benign finding requiring "watchful waiting"
  2. Do not assume all TOF requires immediate neonatal repair - Individualized timing based on weight, symptoms, and anatomy optimizes outcomes 2, 4
  3. Do not use circulatory arrest routinely - Management protocols avoiding circulatory arrest show excellent outcomes with low morbidity 4
  4. Do not neglect long-term follow-up - Most patients require reintervention in adulthood despite excellent initial surgical results 5

Expected Outcomes

With contemporary management, TOF demonstrates excellent short- and long-term survival 2. The 2001 series using individualized surgical timing reported 2.1% mortality and only 3% reoperation rate after complete repair 4. However, morbidity remains common in adulthood, necessitating lifelong surveillance and eventual reintervention in most patients 5.

References

1
Research

Classic imaging signs of congenital cardiovascular abnormalities.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2007

Related Questions

What is the recommended management for Tetralogy of Fallot, including timing of definitive repair, acute hypercyanotic spell treatment, and long‑term follow‑up?
What are the echocardiographic findings in a patient with tetralogy of Fallot?
In a 23-year-old woman with prior Tetralogy of Fallot repair presenting with dyspnea, palpitations, a single S1 and a grade 2/4 early diastolic decrescendo murmur that intensifies with inspiration at the left sternal border, what is the most likely diagnosis?
What is the appropriate heart rate control strategy for a patient with repaired tetralogy of Fallot?
In a 16-year-old male with repaired tetralogy of Fallot who now has harsh high-pitched sounds in the lower lung fields and new light-headedness, what is the appropriate evaluation and management?
What is the diagnosis and recommended management for a patient with normal serum iron, elevated transferrin and total iron‑binding capacity, low ferritin, and low transferrin saturation?
Can a recipient be transfused with two different blood groups in close succession (short interval)?
How does thyroid disease affect anemia and iron‑deficiency anemia?
What is the recommended initial management for a tender, enlarging right inguinal lymph node measuring 0.8 × 0.5 cm with a preserved fatty hilum on ultrasound in a patient without systemic symptoms?
Tell me about the C-reactive protein (CRP) laboratory test.
What are the interactions between methotrexate and celecoxib (Celebrex)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.